This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
All content for Higher Exchanges is the property of Higher Exchanges and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
In this episode of Higher Exchanges, we sit down with Ron Gershoni, CEO and co-founder of Jetty Extracts — one of California’s longest-standing cannabis brands — to explore what it takes to build, protect, and scale a cannabis brand in today’s challenging market. We cover: 🚀 Jetty’s founding story and lessons from a decade of brand building💨 From the first vape to solventless, pre-rolls, and product innovation🛡 How Jetty navigated “Vape Gate” and built consumer trust through clean products🌱 T...
Higher Exchanges
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
